Advertisement

Topics

Companies Related to "ProSolv CardioVascular" [Most Relevant Company Matches] [Advanced Search Results] RSS

12:43 EDT 25th March 2019 | BioPortfolio

Here are the most relevant search results for "ProSolv CardioVascular" found in our extensive corporate database of over 50,000 company records.

Showing "ProSolv CardioVascular" Companies 1–25 of 694

Extremely Relevant

ProSolv CardioVascular

Founded in 1989 as Problem Solving Concepts, Inc. (ProSolv) and acquired by FUJIFILM Medical Systems in January 2007, the company is a leading provider of enterprise-level information management solutions for the clinical analysis and management of digital medical images for cardiology. ProSolv CardioVascular's software solutions consist of advanced reporting and image management software, compre...


Relevant

Cardiovascular Consultants, Ltd.

Cardiovascular Consultants, Ltd., founded in 1986 by Dr. Andrei Damian, is dedicated to providing patients in Phoenix and surrounding areas with the most advanced and appropriate cardiovascular care to achieve quality of life. Today Cardiovascular Consultants has 38 physicians and 15 mid-level providers in 17 locations, and is one of the largest cardiovasc...

Cardiovascular Consultants Ltd.

Cardiovascular Consultants Ltd., founded in 1986 by Dr. Andrei Damian, is dedicated to providing patients in Phoenix and surrounding areas with the most advanced and appropriate cardiovascular care to achieve quality of life. Today Cardiovascular Consultants has 36 physicians and 14 mid-level providers in 15 locations, and is one of the largest cardiovascu...


Embrella Cardiovascular, Inc.

Embrella Cardiovascular™, Inc., is dedicated to creating a new standard-of-care for cerebral embolic protection during cardiovascular procedures. Embrella's Embolic Deflector®, an aortic embolic protection device which acts as a protective shield to reduce the incidence of embolization to the brain, has been granted CE Mark approval. Embrella is a ...

Cardiovascular Consultants

Cardiovascular Consultants is a medical practice that specializes exclusively in the diagnosis, treatment, prevention and management of cardiovascular diseases and conditions. What makes us different is our approach to your care.

Penwest Pharmaceuticals

Penwest Pharmaceuticals is engaged in the research, development and commercialization of novel drug delivery technologies. Based on its extensive expertise in developing and manufacturing tabletting ingredients for the pharmaceuticalindustry, the Company has developed its proprietary TIMERx(R) controlled release drug delivery technology, which is applicable to a broad range of orally administered ...

CorMatrix Cardiovascular, Inc.

CorMatrix Cardiovascular holds an exclusive license from Purdue University to research, develop, manufacture and market naturally occurring ECM products for cardiovascular applications. The company currently has U.S. clearance and European approval with a CE Mark for its ECM Technology as an implant for pericardial closure and for use in cardiac tissue repair.

Cardiovascular Institute of the South (CIS)

CIS is one of the most respected groups of cardiologists, representing nearly every specialty in heart and circulatory medicine. With a team of nearly 450 dedicated team members, CIS serves communities throughout Louisiana, as well as national and international patients, at its 10 clinics. CIS consistently positions itself at the forefront of technology by providing the most up-to-date technolog...

Tyler Cardiovascular Consultants

To provide high-quality preventive, diagnostic and therapeutic cardiovascular services in order to promote cardiovascular health for our patients.To be the premiere group providing quality cardiovascular services and research in East Texas.Our Values • Excellent Quality & Service...for our patients and referring physicians • Honesty, Integrity & Compassion...in our activities with our employee...

miRagen Therapeutics, Inc.

Cardiovascular disease is the leading cause of death globally. Astonishingly, in the United States, every 37 seconds a person dies from cardiovascular disease. For survivors, life changes dramatically after an adverse heart event. Because of the significant toll that cardiovascular and muscle disease takes on patients, miRagen Therapeutics, Inc., was found...

Cardiovascular Research Foundation of Southern California

The CVRF is a 501(3)(c) non-profit charitable organization that was founded in 2007 as the non-profit research arm of the Cardiovascular Medical Group of Southern California, a specialty cardiovascular practice that has been in practice for nearly 40 years. The Foundation currently is engaged in numerous research studies and aims to raise awareness of the ...

Probably Relevant

Medicure

Medicure Inc. is a cardiovascular drug discovery and development Company focused on developing effective therapeutics for unmet needs in the field of cardiovascular medicine, the largest pharmaceutical sector with annual global sales of over US $70 billion. Medicure was founded in 1997 by the renowned cardiovascular researcher, Naranjan S. Dhalla, Ph.D., Professor and Director, Institute of Cardio...

The Richard B. and Lynne V. Cheney Cardiovascular Institute

The Richard B. and Lynne V. Cheney Cardiovascular Institute at The George Washington University was established in 2006. The Institute's mission is to promote clinical research, education, patient care and community service with the goal of accelerating the pace of scientific discovery, reducing mortality and improving the quality of life of Americans with cardiovascular disease. For more informa...

Pivotal Therapeutics Inc.

With offices in Toronto, Canada and Boca Raton, Florida, Pivotal Therapeutics is a publicly traded (OTCQX: PVTTF; CNSX: PVO) specialty pharmaceutical company with a focus on cardiovascular and overall health. Pivotal Therapeutics' lead product VASCAZENTM is a prescription only medical food formulated to meet the dietary Omega-3 deficient needs of patients ...

MyoKardia, Inc.

MyoKardia is dedicated to revolutionizing the treatment of genetic cardiovascular disease. The company’s proprietary platform combines recent breakthroughs in muscle biology with leading-edge cardiovascular disease genetics. This personalized, genetically targeted approach focuses on the underlying cause of disease and has the potential to drastically...

Myogen, Inc.

Myogen is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders. We believe that our advanced understanding of the biology of cardiovascular disease combined with our clinical development expertise in cardiovascular therapeutics provide us with the capability to discover novel therapies, ...

Cardiovascular Clinical Studies, Inc

Cardiovascular Clinical Studies ("CCS") is an academically oriented cardiovascular research organization that was formed by Marvin A. Konstam, M.D., Chief of Cardiology at New England Medical Center and James E. Udelson, M.D., Associate Chief of Cardiology at New England Medical Center.

Texas Heart Institute at St. Luke’s Episcopal Hospital

The Texas Heart Institute (www.texasheart.org), founded by world-renowned cardiovascular surgeon Dr. Denton A. Cooley in 1962, is a nonprofit organization dedicated to reducing the devastating toll of cardiovascular disease through innovative and progressive programs in research, education and improved patient care. Together with its clinical partner, St. ...

Synvista Therapeutics, Inc.

Synvista Therapeutics is a biopharmaceutical company developing drugs to treat and prevent cardiovascular disease and nephropathy in people with diabetes. The Company believes it has identified several product candidates that represent novel approaches to some of the largest pharmaceutical markets. The Company's portfolio includes orally bioavailable, organoselenium mimics of glutathione pero...

CardioNexus Corporation

CardioNexus Corporation is an affiliated company of Panasonic Healthcare dedicated to reducing cardiovascular disease through early detection and prevention. CardioNexus’ flagship product, the CardioHealth® Station, is a new multi-modality initiative to advance cardiovascular health assessment for the prevention of heart attack and stroke. The advanced, ...

The Lown Cardiovascular Research Foundation

The Lown Foundation’s mission to promote heart health and curb overtreatment in medicine is achieved through cardiovascular research, training, and global outreach activities. For more information please visit www.lownfoundation.org.

Heart & Vascular Center of Arizona

The Heart & Vascular Center of Arizona (HVCA) specializes in non-invasive, invasive and interventional cardiology as well as peripheral vascular disease and intervention. The HVCA is committed to offering their patients the highest quality, cost-effective and readily accessible cardiovascular services. With over 25 years of experience, the cardiologists at HVCA are leaders in cardiovascular diagno...

Aterovax SA

Aterovax is developing innovative products for the cardiovascular disease market based on a unique understanding of atherosclerosis, the condition responsible for most cardiovascular problems. Aterovax’s first product is a diagnostic blood test to measure activity of secretory phospholipase A2 (sPLA2), a powerful biomarker that provides physicians wit...

Aviir, Inc.

Founded in 2005 by cardiologists and researchers from the Stanford University School of Medicine , Aviir is focused on the discovery, development and commercialization of innovative diagnostic and predictive cardiovascular tests, employing state of the art laboratory diagnostic methods. Aviir’s CLIA laboratory in Irvine, CA offers a range of tests for...

Critical Diagnostics Critical Diagnostics

Critical Diagnostics (www.criticaldiagnostics.com) develops novel biomarkers to help physicians optimize patient care in cardiovascular diseases, while containing healthcare costs. The Presage ST2 Assay has been CE Marked and cleared by the US FDA. Critical Diagnostics has exclusive worldwide rights to ST2 for the diagnosis and prognosis of cardiovascular ...


More From BioPortfolio on "ProSolv CardioVascular"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks